text.skipToContent text.skipToNavigation
Pharma & Biotech

Pooled 10- Donor Human Hepatocytes, Suspension

Catalog #: HUCS10P
Cryopreserved Pooled 10-donor Suspension Qualified hepatocytes is a pool of hepatocytes derived from at least10 different donors to better mimic the average population. These are characterized for high viability and general Phase I and Phase II metabolism activity in short term suspension metabolism assays.
Compare
AMP

Product Overview

Cryopreserved Pooled 10-donor Suspension Qualified hepatocytes is a pool of hepatocytes derived from at least 10 different donors to better mimic the average population. These are characterized for high viability and general Phase I and Phase II metabolism activity in short term suspension metabolism assays. The Suspension Qualified hepatocytes are ideally suited for short-term (<4hrs) in vitro drug clearance assays. The Suspension Qualified hepatocytes are not suitable for applications that require hepatocytes cultured in adhered monolayer.

Benefits

Precharacterized for general metabolism and activity of 6 CYP enzymes

Applications

Suspension metabolism studies

Content & Storage

Content

Cryo Vial, >5 million viable cells

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Webinar -Hepatocytes in the Drug Development Pipeline

Overview of how primary hepatocytes are used in drug development

Be Among the First to Know

CellAlertTM Sign-up

Register to receive email alerts when fresh hepatocytes or when new lots of cryopreserved hepatocytes become available.

Human Hepatocyte Inventory

Human

Inventory

View donor information and select characteristics of currently available human hepatocyte lots. Table includes single donor and pooled donor lots in either suspension or plateable formats

Engineering Culture Platforms to Mimic Liver Diseases

Webinar

Learn from Dr. Salman Khetani, University of Illinois at Chicago, how multiple liver cell-types including hepatocytes, Kupffer, stellate, and endothelial cells can be engineered together to model human liver disease phenotypes in culture.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok